stocksymbol=PFE&prnumber =101020170 (Note: You may have to copy this link into your browser then press the …
AZN stock was down $7.28, or 9.07%, in pre-market trading. YTD, the stock is up 37.07%. PFE stock was up 38 cents, or 1.3%, in pre-market trading. YTD, the stock is down 4.4%. Shares of AstraZeneca (AZN) offer a dividend yield of 3.49% …
The drugmaker's stock slipped 1 percent, but the fallout is minimal. Crestor is already an FDA-approved blockbuster. Sales of the drug soared 42 percent during the first nine months of 2007, reaching nearly $2 billion. Merck had better luck with …
ICU Medical Inc : ICU Medical Inc to acquire the Hospira Infusion Systems business from Pfizer Inc for $1 billion in cash and stock . Deal for $1 billion . Pfizer will receive approximately $400 million in newly issued shares of ICU Medical …
Shares of Pfizer Inc (NYSE:PFE) have bearishly opened below the pivot of $34.07 today and have reached the first support level of $33.94. Analysts will be watching for a cross of the next downside pivot targets of $33.83 and $33.59. Over the …
GlaxoSmithKline's new chief executive said on Tuesday that the British drugmaker would have a look at Pfizer Inc's consumer products business, but would not overpay for the asset. GlaxoSmithKline's new chief executive said on …
GlaxoSmithKline (GSK) is a leading player in the global respiratory market with a major focus on the asthma and chronic obstructive pulmonary disease (or COPD) segments. The company has estimated global asthma prevalence to be …